CRISPR Therapeutics AG
(NASDAQ : CRSP)

( )
CRSP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
-1.07%73.6914.4%$580.10m
AMGNAmgen Inc.
-2.76%192.071.2%$565.07m
GILDGilead Sciences, Inc.
-2.64%65.570.9%$530.36m
CELGCelgene Corporation
-2.21%68.201.2%$520.26m
BIIBBiogen Inc.
-1.75%314.551.3%$359.40m
ILMNIllumina, Inc.
-2.44%326.463.5%$350.15m
REGNRegeneron Pharmaceuticals, Inc.
0.70%381.172.6%$273.12m
VRTXVertex Pharmaceuticals Incorporated
-1.94%170.061.9%$226.47m
AAgilent Technologies, Inc.
-2.49%69.371.5%$225.54m
ALXNAlexion Pharmaceuticals, Inc.
-2.67%109.432.0%$146.61m
INCYIncyte Corporation
-1.55%66.252.5%$97.76m
EXASExact Sciences Corporation
0.68%68.3125.3%$93.39m
SRPTSarepta Therapeutics, Inc.
-2.05%119.5215.4%$90.77m
NKTRNektar Therapeutics
-3.92%36.515.5%$84.08m
SGENSeattle Genetics, Inc.
-0.85%60.486.6%$81.91m

Company Profile

CRISPR Therapeutics AG engages in the development and commercializtion of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.